EuBiologics Co., Ltd. (KOSDAQ: 206650)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,130
-450 (-3.58%)
Dec 19, 2024, 9:00 AM KST

EuBiologics Revenue

In the year 2023, EuBiologics had annual revenue of 69.37B KRW with 25.06% growth. EuBiologics had revenue of 26.89B in the quarter ending December 31, 2023, with 54.38% growth.

Revenue
69.37B
Revenue Growth
+25.06%
P/S Ratio
6.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
433.66B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202369.37B13.90B25.06%
Dec 31, 202255.47B16.08B40.83%
Dec 31, 202139.38B10.90B38.24%
Dec 31, 202028.49B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition